Literature DB >> 19181963

Impaired vascular function in mice with an active cytomegalovirus infection.

R B Gombos1, V Wolan, K McDonald, D G Hemmings.   

Abstract

Human cytomegalovirus (CMV) is implicated in vascular complications through endothelial dysfunction. However, the effect of in vivo infections on vascular function in isolated arteries has not been examined. In pregnancy, systemic and uterine vascular adaptations accommodate increased blood volume through several mechanisms, including decreased sensitivity to vasoconstrictors and increased production of endothelial-dependent vasodilators. We hypothesized that an active in vivo CMV infection would reduce vasodilation of isolated arteries to the endothelial-dependent vasodilator methacholine and increase vasoconstriction to the alpha(1)-adrenergic receptor agonist phenylephrine and that these CMV-induced changes would be accentuated in late pregnancy. A mouse CMV infection model was used to study vascular responses in isolated mesenteric and uterine arteries from nonpregnant and late pregnant mice. In the mouse, CMV is not transmitted to the fetus. Accordingly, there was no evidence of active infection in any fetus examined, even though an active infection was found in salivary glands, uterine and mesenteric arteries, and placentas. Contrary to our hypothesis, increased endothelial-dependent vasodilation was found in mesenteric arteries from infected compared with uninfected nonpregnant and pregnant mice These data implicate active CMV infections in hypotensive disorders. Similarly, increased vasodilation was found in uterine arteries from infected vs. uninfected nonpregnant mice. However, this was completely reversed in infected compared with uninfected late pregnant mice in which vasodilation in uterine arteries was significantly reduced. Uterine arteries from infected pregnant mice also showed increased vasoconstriction to phenylephrine. Maternal infection led to decreased placental weights but had no effect on fetal weights in late pregnancy. These novel data demonstrate abnormal systemic and uterine vascular responses during an active CMV infection in both nonpregnant and late pregnant mice. Importantly, despite reduced placental weights, fetal weights were maintained, suggesting effective intrauterine compensation in the mouse model.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19181963     DOI: 10.1152/ajpheart.01027.2008

Source DB:  PubMed          Journal:  Am J Physiol Heart Circ Physiol        ISSN: 0363-6135            Impact factor:   4.733


  5 in total

1.  Cytomegalovirus infection leads to microvascular dysfunction and exacerbates hypercholesterolemia-induced responses.

Authors:  Mikhail V Khoretonenko; Igor L Leskov; Stephen R Jennings; Andrew D Yurochko; Karen Y Stokes
Journal:  Am J Pathol       Date:  2010-08-27       Impact factor: 4.307

2.  Vascular dysfunction in young, mid-aged and aged mice with latent cytomegalovirus infections.

Authors:  R B Gombos; J C Brown; J Teefy; R L Gibeault; K L Conn; L M Schang; D G Hemmings
Journal:  Am J Physiol Heart Circ Physiol       Date:  2012-11-02       Impact factor: 4.733

3.  Virome Analysis Reveals No Association of Head and Neck Vascular Anomalies with an Active Viral Infection.

Authors:  Nora Franke; Michael Bette; André Marquardt; Thomas Briese; W Ian Lipkin; Christopher Kurz; Jovine Ehrenreich; Elisabeth Mack; Bianka Baying; Vladimir Beneš; Fiona R Rodepeter; Andreas Neff; Afshin Teymoortash; Behfar Eivazi; Urban Geisthoff; Boris A Stuck; Udo Bakowsky; Robert Mandic
Journal:  In Vivo       Date:  2018 Nov-Dec       Impact factor: 2.155

Review 4.  Ly49 receptors: innate and adaptive immune paradigms.

Authors:  Mir Munir A Rahim; Megan M Tu; Ahmad Bakur Mahmoud; Andrew Wight; Elias Abou-Samra; Patricia D A Lima; Andrew P Makrigiannis
Journal:  Front Immunol       Date:  2014-04-02       Impact factor: 7.561

Review 5.  Maternal natural killer cells at the intersection between reproduction and mucosal immunity.

Authors:  Evgeniya V Shmeleva; Francesco Colucci
Journal:  Mucosal Immunol       Date:  2021-04-26       Impact factor: 7.313

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.